On Apr 9, the International Monetary Fund (IMF) reduced its growth forecast for the year once again. The international lending body believes economic headwinds including monetary tightening by the Federal Reserve and trade conflicts could derail global growth in the months ahead.
The IMF also cited industrial production data and surveys of purchasing managers to justify its projection for slower global growth in 2019. Meanwhile, even as China implements stimulus measures to boost its flagging economy, the situation in Eurozone remains worrying.
With a lurking global economic slowdown, it makes sense to fortify your portfolio for such conditions. In such an event, demand for products and services generated by utilities, consumer staples and medical companies remain invariant. Investing in stocks from these sectors looks like a smart option.
IMF Cuts Global Growth Projections
On Tuesday, the IMF reduced its forecast for global economic growth for the third time in six months. The international lending body now believes that global growth will clock in at 3.3% for 2019, 0.2% lower than the estimate released in January. However, its projection for 2020 remained flat at 3.6%.
A major headwind for the global economy is the lingering trade war between the United States and China. The IMF thinks that the inability to come to an agreement and the resultant tariff barriers would result in “higher costs of imported intermediate and capital goods and higher final goods prices for consumers.”
And despite the Federal Reserve’s recent attempts to step away from its earlier hawkish standpoint, the IMF thinks a change in the monetary stance of central banks could also imperil global growth. The IMF thinks that market expectations for the federal funds rate is well below the Fed’s projections.
According to the global lender, this is likely to “result in higher US interest rates, renewed dollar appreciation, and tighter financial conditions” for emerging economies with large volumes of debt.
Global Stimulus Needed, Eurozone Vulnerable
Speaking at a news conference in Washington on Tuesday, IMF chief economist Gita Gopinath said that this was a “delicate moment for the global economy.” The IMF believes that coordinated global stimulus measures would be needed to cushion the impact of a sharp downturn. Gopinath added that a dovish monetary approach would also be needed to counter the slowdown.
According to the IMF, most of the global economy’s likely troubles this year will originate from problems in developed economies, including leading members of the EU. Apart from the impact of an inevitable Brexit, other factors are impeding growth in the region.
The outlook for Germany, the Eurozone’s economic powerhouse, has softened because of sluggish demand for exports and a decline in consumer spending. Tougher emission standards are also likely to weigh on sales of cars produced in the country.
The IMF’s decision to cut global growth projections is likely to rattle investors across the world. The risks it lays out while justifying this reduction are very real and likely to weigh on the pace of economic expansion in the near term.
Investing in stocks whose demand remains invariant even during an all-encompassing slowdown looks prudent at this time. Picking utilities, consumer staples and medical stocks for your portfolio would be a good option. However, picking winning stocks may prove to be difficult.
This is where our VGM Score comes in. Here V stands for Value, G for Growth and M for Momentum and the score is a weighted combination of these three scores. Such a score allows you to eliminate the negative aspects of stocks and select winners. However, it is important to keep in mind that each Style Score will carry a different weight while arriving at a VGM Score.
We have narrowed down our search to the following stocks based on a good Zacks Rank and VGM Score.
Unilever PLC UL is engaged in manufacturing of branded and packaged consumer goods, including food, detergents and personal care product on a global basis.
Unilever has a Zacks Rank #1 (Strong Buy) and VGM Score of A. The company has expected earnings growth of 2.5% for the current year. The Zacks Consensus Estimate for the current year has improved by 6% over the past 30 days.
Medifast, Inc. MED is a leading manufacturer and distributor of clinically proven healthy living and nutritional products.
Medifast has a VGM Score of B. The company has expected earnings growth of 41.1% for the current year. The stock has a Zacks Rank #1. You can see the complete list of today’s Zacks #1 Rank stocks here.
Molina Healthcare, Inc. MOH is a multi-state managed care organization participating exclusively in government-sponsored health care programs.
Molina Healthcare has a Zacks Rank #2 (Buy) and VGM Score of A. The Zacks Consensus Estimate for the current year has improved by 6.5% over the past 60 days.
Johnson and Johnson, Inc. JNJ focuses on the development, manufacturing, and marketing of pharmaceutical, medical and consumer-related healthcare products.
Johnson and Johnson has a Zacks Rank #2 and VGM Score of B. The company has expected earnings growth of 4.9% for the current year. The Zacks Consensus Estimate for the current year has improved by 0.1% over the past 30 days.
MYR Group Inc. MYRG is a holding company of leading specialty contractors serving the electrical infrastructure market throughout the United States and Canada.
MYR Group has a Zacks Rank #2 and VGM Score of B. The company has expected earnings growth of 24.9% for the current year.
Zacks' Top 10 Stocks for 2019
In addition to the stocks discussed above, would you like to know about our 10 finest buy-and-holds for the year?
Who wouldn't? Our annual Top 10s have beaten the market with amazing regularity. In 2018, while the market dropped -5.2%, the portfolio scored well into double-digits overall with individual stocks rising as high as +61.5%. And from 2012-2017, while the market boomed +126.3, Zacks' Top 10s reached an even more sensational +181.9%.
See Latest Stocks Today >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Johnson & Johnson (JNJ) : Free Stock Analysis Report
MEDIFAST INC (MED) : Free Stock Analysis Report
Unilever PLC (UL) : Free Stock Analysis Report
Molina Healthcare, Inc (MOH) : Free Stock Analysis Report
MYR Group, Inc. (MYRG) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research